Relenza

Medicinal product

(Invented) name

Relenza

Active substance (s)

Zanamiviras

Strength

5 mg/dozėje

Pharmaceutical form

dozuoti įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AH01, Zanamivir

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

2007-06-27

Date of renewal

2009-09-25

Documents

0769 Pakuotės lapelis 2023 12 18.docx

0769 Relenza PCS PL 2023 12 18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

SE/H/0180/001/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Zanamiviras	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
20748	23715	1023715	lizdinė plokštelė	diskas (4 dozės) N1 ir inhaliatorius		Receptinis	LT/1/07/0769/001	Netiekiama	-	-	No	-	-
23099	25823	1025823	lizdinė plokštelė	diskas (4 dozės) N5 ir inhaliatorius		Receptinis	LT/1/07/0769/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2009-09-25	Perregistruotas
2007-06-27	Registruotas